Clinical Trial

Intraocular Gas Tamponade for Treatment of Large Idiopathic Macular Holes

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to evaluate the visual and anatomical outcomes of large (410-1000 μm) full-thickness macular holes repair surgery using perfluoropropane (15% C3F8), sulfur hexafluoride (20% SF6) gas tamponade.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-14.
Trial Details
NCT Number NCT06927544
Lead Sponsor The Filatov Institute of Eye Diseases and Tissue Therapy
Collaborators: Ukrainian Vitreoretinal Society
Conditions Idiopathic Macular Hole, Macular Hole, Macular Holes, Full Thickness Macular Hole
Enrollment 100 participants
Start Date 2025-02-01
Primary Completion 2027-02-01 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-17